A new study reveals that dasatinib and quercetin (D+Q) cause demyelination in mice, raising safety concerns as over 30 clinical trials test the combo for age-related diseases. A study in Nature Aging ...
A 2025 study shows CEMIP blocks remyelination by producing hyaluronan fragments, linking multiple sclerosis to cognitive aging and opening new therapy avenues for brain health. Recent research uncover...
